In a murine MLL-AF9 AML cell model, shRNA or (+)-JQ1 treatments induced cell differentiation and led to depletion of leukemia stem cells and a global reduction in the expression of Myc target genes. Here, KMT2A is linked to acute myeloid leukemia.